Stratec SE (VIE:SBSG)

Austria flag Austria · Delayed Price · Currency is EUR
22.10
-0.40 (-1.78%)
At close: Feb 2, 2026
-24.57%
Market Cap261.35M -37.8%
Revenue (ttm)260.25M +1.8%
Net Income15.36M +21.8%
EPS1.26 +22.7%
Shares Outn/a
PE Ratio17.02
Forward PE15.46
Dividend0.60 (2.67%)
Ex-Dividend DateJun 30, 2025
Volumen/a
Average Volume7
Open22.25
Previous Close22.50
Day's Range22.10 - 22.25
52-Week Range19.78 - 32.65
Betan/a
RSI39.66
Earnings DateApr 28, 2026

About Stratec SE

Stratec SE, together with its subsidiaries, provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally. The company designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. It also provides consumables for diagnostics and medical applications; and integrating instrumentation and software. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1... [Read more]

Industry Laboratory Analytical Instruments
Founded 1979
Employees 1,420
Stock Exchange Vienna Stock Exchange
Ticker Symbol SBSG
Full Company Profile

Financial Performance

In 2024, Stratec SE's revenue was 257.62 million, a decrease of -4.73% compared to the previous year's 270.41 million. Earnings were 16.02 million, an increase of 4.24%.

Financial Statements